The
Board of International Biotechnology Trust Plc (IBT) today announced
the appointment, with immediate effect, of UBS Warburg Ltd. ("UBS
Warburg") as broker and adviser to the Company.
Kate
Bingham, General Partner at Schroder Ventures Life Sciences, advisors
to IBT, commented on the appointment:
"UBS
Warburg has a large and experienced investment trust as well as healthcare
team. We believe this combination of experience, coupled with a leading
position in the market makes them an excellent broker to IBT."
Ivo
Coulson, Executive Director at UBS Warburg said:
"We
are delighted to be working with the Schroder Venture Life Sciences
(SVLS) team, which has been appointed as the advisors to IBT. SVLS's
hands-on approach and its global presence will add value to IBT's investment
portfolio."
For
further information, please contact:
Schroders
Investment Managers
John Spedding
Tel: 020 7658 3206
F. 0207 658 2422
Email: john.spedding@schroders.com
Schroder
Ventures Life Sciences
Jodie Van Elst
Tel: 020 7421 7070
Fax: 020 7421 7077
Email: jodie.vanelst@svlifesciences.com
GCI
Financial
Annabel O'Connor
Tel: 020 7398 0800
Fax: 020 7398 0888
Email:aoconnor@gcifinancial.com